$NB
NIOCORP DEVELOPMENTS LTD Stock $nb

$nb Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000153949723000271 Filed on February 13, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2021 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.562M	$553.0K	$1.656M
YoY Change	382.1%	-66.61%	115.06%
% of Gross Profit
Research & Development	$1.410M	$1.317M	$491.0K
YoY Change	66.86%	168.23%	158.42%
% of Gross Profit
Depreciation & Amortization	$1.000K	$0.00	$0.00
YoY Change	0.0%
% of Gross Profit
Operating Expenses	$29.19M	$2.201M	$3.028M
YoY Change	2006.2%	-27.31%	148.2%
Operating Profit
YoY Change
Interest Expense	$142.0K	$82.00K	-$430.0K
YoY Change	-133.02%	-119.07%	-490.91%
% of Operating Profit
Other Income/Expense, Net			$0.00
YoY Change			-100.0%
Pretax Income	-$29.62M	-$2.208M	-$3.458M
YoY Change	1531.11%	-36.15%	220.19%
Income Tax	-$186.0K		$0.00
% Of Pretax Income
Net Earnings	-$29.34M	-$2.208M	-$3.458M
YoY Change	1515.8%	-36.15%	220.19%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$1.03	-$0.01	-$13.23K
COMMON SHARES
Basic Shares Outstanding	282.5M shares	279.5M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q1	2022 Q4	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.145M	$424.0K	$4.866M
YoY Change	106.26%	-91.29%	3643.08%
Cash & Equivalents	$7.145M	$424.0K	$4.866M
Short-Term Investments
Other Short-Term Assets	$96.00K	$112.0K	$279.0K
YoY Change	-82.26%	-59.86%	458.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$7.241M	$536.0K	$5.145M
YoY Change	80.8%	-89.58%	2758.33%
LONG-TERM ASSETS
Property, Plant & Equipment	$17.17M	$16.98M	$17.06M
YoY Change	0.75%	-0.47%	57.41%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$7.000K	$9.000K	$11.00K
YoY Change	-30.0%	-18.18%	10.0%
Other Assets	$35.00K	$4.373M	$35.00K
YoY Change	0.0%	12394.29%	-12.5%
Total Long-Term Assets	$17.22M	$21.37M	$17.11M
YoY Change	0.73%	24.88%	57.11%
TOTAL ASSETS
Total Short-Term Assets	$7.241M	$536.0K	$5.145M
Total Long-Term Assets	$17.22M	$21.37M	$17.11M
Total Assets	$24.46M	$21.90M	$22.25M
YoY Change	15.93%	-1.59%	101.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.055M	$739.0K	$186.0K
YoY Change	3383.05%	297.31%	-71.82%
Accrued Expenses	$149.0K	$1.155M	$348.0K
YoY Change	-79.86%	231.9%	-58.07%
Deferred Revenue
YoY Change
Short-Term Debt	$1.289M	$2.000M	$2.000M
YoY Change	-35.55%	0.0%	-47.64%
Long-Term Debt Due	$0.00	$502.0K	$0.00
YoY Change	-100.0%		-100.0%
Total Short-Term Liabilities	$4.678M	$7.088M	$2.534M
YoY Change	-13.11%	179.72%	-66.92%
LONG-TERM LIABILITIES
Long-Term Debt	$12.26M	$0.00	$4.262M
YoY Change		-100.0%	2944.29%
Other Long-Term Liabilities	$5.303M	$0.00	$66.00K
YoY Change	11952.27%	-100.0%	-56.0%
Total Long-Term Liabilities	$5.303M	$0.00	$4.328M
YoY Change	11952.27%	-100.0%	1392.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.678M	$7.088M	$2.534M
Total Long-Term Liabilities	$5.303M	$0.00	$4.328M
Total Liabilities	$34.74M	$7.088M	$6.862M
YoY Change	539.92%	3.29%	-13.69%
SHAREHOLDERS EQUITY
Retained Earnings	-$146.0M	-$115.2M	-$104.5M
YoY Change	37.38%	10.21%
Common Stock	$134.4M	$131.0M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$12.51M	$14.81M	$15.39M
YoY Change
Total Liabilities & Shareholders Equity	$24.46M	$21.90M	$22.25M
YoY Change	15.93%	-1.59%	101.03%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2021 Q4
OPERATING ACTIVITIES
Net Income	-$29.34M	-$2.208M	-$3.458M
YoY Change	1515.8%	-36.15%	220.19%
Depreciation, Depletion And Amortization	$1.000K	$0.00	$0.00
YoY Change	0.0%
Cash From Operating Activities	-$7.341M	-$2.386M	-$1.349M
YoY Change	404.19%	76.87%	107.54%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$21.00K
YoY Change
Cash From Investing Activities	$0.00	$21.00K	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	14.17M	-526.0K	299.0K
YoY Change	141580.0%	-275.92%	35.91%
NET CHANGE
Cash From Operating Activities	-7.341M	-2.386M	-1.349M
Cash From Investing Activities	0.000	21.00K	0.000
Cash From Financing Activities	14.17M	-526.0K	299.0K
Net Change In Cash	6.827M	-2.891M	-1.050M
YoY Change	-572.13%	175.33%	144.19%
FREE CASH FLOW
Cash From Operating Activities	-$7.341M	-$2.386M	-$1.349M
Capital Expenditures	$0.00	$0.00	$0.00
Free Cash Flow	-$7.341M	-$2.386M	-$1.349M
YoY Change	404.19%	76.87%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001512228
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2022Q2	us-gaap	Deferred Costs DeferredCosts		usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2022	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2021Q4	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings		usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets		usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
	niobf	Payments Of Deferred Transaction Costs PaymentsOfDeferredTransactionCosts		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction		usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
	us-gaap	Net Income Loss NetIncomeLoss	-4762000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-115159000	usd
	us-gaap	Capital Expenditure Discontinued Operations CapitalExpenditureDiscontinuedOperations	109005000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent		usd
CY2022Q2	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	niobf	Class Of Warrant Or Right Granted ClassOfWarrantOrRightGranted		shares
	niobf	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised		shares
	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	5000001	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-55710
	dei	Entity Registrant Name EntityRegistrantName	NioCorp Developments Ltd.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A1
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1262185
	dei	Entity Address Address Line1 EntityAddressAddressLine1	7000 South Yosemite Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 115
	dei	Entity Address City Or Town EntityAddressCityOrTown	Centennial
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80112
	dei	City Area Code CityAreaCode	855
	dei	Local Phone Number LocalPhoneNumber	264-6267
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	282466201	shares
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	424000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5280000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	112000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	402000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	536000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	5682000	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	4338000	usd
CY2022Q4	us-gaap	Deposits Assets DepositsAssets	35000	usd
CY2022Q2	us-gaap	Deposits Assets DepositsAssets	35000	usd
CY2022Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	9000	usd
CY2022Q2	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	10000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	58000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	94000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	840000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	850000	usd
CY2022Q4	us-gaap	Capitalized Costs Mineral Interests In Unproved Properties CapitalizedCostsMineralInterestsInUnprovedProperties	16085000	usd
CY2022Q2	us-gaap	Capitalized Costs Mineral Interests In Unproved Properties CapitalizedCostsMineralInterestsInUnprovedProperties	16085000	usd
CY2022Q4	us-gaap	Assets Assets	21901000	usd
CY2022Q2	us-gaap	Assets Assets	22756000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4520000	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	817000	usd
CY2022Q4	us-gaap	Due To Officers Or Stockholders Current DueToOfficersOrStockholdersCurrent	2000000	usd
CY2022Q2	us-gaap	Due To Officers Or Stockholders Current DueToOfficersOrStockholdersCurrent	2000000	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	502000	usd
CY2022Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	2169000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	66000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	82000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7088000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5068000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	7088000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	5091000	usd
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	282420651	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	276670606	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	130995000	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	129055000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-115159000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-110397000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1023000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-993000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14813000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	17665000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21901000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22756000	usd
CY2022Q4	us-gaap	Labor And Related Expense LaborAndRelatedExpense	291000	usd
CY2021Q4	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1232000	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	584000	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1551000	usd
CY2022Q4	us-gaap	Professional Fees ProfessionalFees	262000	usd
CY2021Q4	us-gaap	Professional Fees ProfessionalFees	424000	usd
	us-gaap	Professional Fees ProfessionalFees	426000	usd
	us-gaap	Professional Fees ProfessionalFees	514000	usd
CY2022Q4	niobf	Exploration Expenditures ExplorationExpenditures	1317000	usd
CY2021Q4	niobf	Exploration Expenditures ExplorationExpenditures	491000	usd
	niobf	Exploration Expenditures ExplorationExpenditures	2605000	usd
	niobf	Exploration Expenditures ExplorationExpenditures	1112000	usd
CY2022Q4	us-gaap	Other General Expense OtherGeneralExpense	331000	usd
CY2021Q4	us-gaap	Other General Expense OtherGeneralExpense	881000	usd
	us-gaap	Other General Expense OtherGeneralExpense	668000	usd
	us-gaap	Other General Expense OtherGeneralExpense	1107000	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	2201000	usd
CY2021Q4	us-gaap	Operating Expenses OperatingExpenses	3028000	usd
	us-gaap	Operating Expenses OperatingExpenses	4283000	usd
	us-gaap	Operating Expenses OperatingExpenses	4284000	usd
CY2022Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	64000	usd
CY2021Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	61000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-109000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-164000	usd
CY2022Q4	us-gaap	Interest Expense InterestExpense	82000	usd
CY2021Q4	us-gaap	Interest Expense InterestExpense	1022000	usd
	us-gaap	Interest Expense InterestExpense	382000	usd
	us-gaap	Interest Expense InterestExpense	1627000	usd
CY2022Q4	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	13000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	13000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	2000	usd
CY2021Q4	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	3000	usd
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	1000	usd
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	5000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2208000	usd
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3992000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4762000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6080000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-2208000	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-3992000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4762000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6080000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-2208000	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-3992000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4762000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6080000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-25000	usd
CY2021Q4	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-14000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-30000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	110000	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2233000	usd
CY2021Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4006000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4792000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5970000	usd
CY2022Q4	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	0.01
CY2021Q4	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	0.01
	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	0.02
	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	0.02
CY2022Q4	niobf	Total Weighted Average Number Of Share Outstanding Basic And Diluted TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted	280562633	shares
CY2021Q4	niobf	Total Weighted Average Number Of Share Outstanding Basic And Diluted TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted	261392248	shares
	niobf	Total Weighted Average Number Of Share Outstanding Basic And Diluted TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted	279244474	shares
	niobf	Total Weighted Average Number Of Share Outstanding Basic And Diluted TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted	259734327	shares
	us-gaap	Net Income Loss NetIncomeLoss	-4762000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6080000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-5000	usd
	us-gaap	Accretion Expense AccretionExpense	283000	usd
	us-gaap	Accretion Expense AccretionExpense	1524000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	13000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	-4000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	-3000	usd
	us-gaap	Depreciation Depreciation	1000	usd
	us-gaap	Depreciation Depreciation	1000	usd
	niobf	Foreign Currency Transaction Gain Loss Before Tax1 ForeignCurrencyTransactionGainLossBeforeTax1	-151000	usd
	niobf	Foreign Currency Transaction Gain Loss Before Tax1 ForeignCurrencyTransactionGainLossBeforeTax1	-225000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1568000	usd
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-4343000	usd
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-2760000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-289000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	255000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-70000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	57000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4124000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2958000	usd
	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings	16000	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	21000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	11000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	21000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	963000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	21000	usd
	niobf	Payments Of Deferred Transaction Costs PaymentsOfDeferredTransactionCosts	537000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	318000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-547000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	645000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-206000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-122000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4856000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2451000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5280000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7317000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	424000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4866000	usd
	us-gaap	Interest Paid Net InterestPaidNet	40000	usd
	niobf	Conversions Of Debt For Common Shares ConversionsOfDebtForCommonShares	1950000	usd
	niobf	Conversions Of Debt For Common Shares ConversionsOfDebtForCommonShares	4522000	usd
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	3800000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	13263000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	299000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	3172000	usd
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1568000	usd
CY2021Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-14000	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-3992000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	14296000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	16735000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	300000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-25000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-2208000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14813000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	13213000	usd
	niobf	Stock Issued During Period Value Stock Warrants Exercised StockIssuedDuringPeriodValueStockWarrantsExercised	543000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	420000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	4522000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1568000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	110000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6080000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	14296000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	17665000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	1950000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-21000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-30000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4762000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14813000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_805_eus-gaap--NatureOfOperations_zCrOFkvd2mqi" style="margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_828_z3z1B243PWT3">DESCRIPTION OF BUSINESS</span></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp Developments Ltd. (“NioCorp” or the “Company”) was incorporated on February 27, 1987, under the laws of the Province of British Columbia and currently operates in <span id="xdx_908_eus-gaap--NumberOfReportableSegments_dxL_uN_c20220701__20221231_z2ybo5bkbDKc" title="Number of reportable segments::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl0539">one</span></span> reportable operating segment consisting of exploration and development of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property (the “Elk Creek Project”) located in southeastern Nebraska.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These interim condensed consolidated financial statements have been prepared on a going concern basis that contemplates the realization of assets and discharge of liabilities at their carrying values in the normal course of business for the foreseeable future. These financial statements do not reflect any adjustments that may be necessary if the Company is unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company currently earns no operating revenues and will require additional capital in order to advance the Elk Creek Project to construction and commercial operation. As further discussed in Note 4, these matters raised substantial doubt about the Company’s ability to continue as a going concern, and the Company is dependent upon the generation of profits from mineral properties, obtaining additional financing and maintaining continued support from its shareholders and creditors. </span></p>
	us-gaap	Basis Of Accounting BasisOfAccounting	<p id="xdx_803_eus-gaap--BasisOfAccounting_zpQqgLWRWMPl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82C_zefMmCgZgdU2">BASIS OF PREPARATION</span></span></td> </tr></table> <p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z4HDRD5XFohj" style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_863_znN7SZHQKgmg">Basis of Preparation and Consolidation</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles of the United States of America (“U.S. GAAP”) and the rules and regulations of the Securities and Exchange Commission (“SEC”). The interim condensed consolidated financial statements include the consolidated accounts of the Company and its wholly owned subsidiaries with all significant intercompany transactions eliminated. The accounting policies followed in preparing these interim condensed consolidated financial statements are those used by the Company as set out in the audited consolidated financial statements for the year ended June 30, 2022. Certain transactions include reference to Canadian dollars (“C$”) where applicable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the opinion of management, all adjustments considered necessary (including reclassifications and normal recurring adjustments) for a fair statement of the financial position, results of operations, and cash flows at December 31, 2022, and for all periods presented, have been included in these interim condensed consolidated financial statements. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to appropriate SEC rules and regulations. These interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended June 30, 2022. The interim results are not necessarily indicative of results for the full year ending June 30, 2023, or future operating periods.</span></p> <p id="xdx_85C_zrxAfXkniW7b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"> </p> <p id="xdx_848_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zNBgn1tplge4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_862_zQzWMEqwoIQ3">Recent Accounting Standards</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Issued and Adopted</span> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2020, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”), which simplifies the accounting for convertible instruments. ASU 2020-06 removes certain accounting models which separate the embedded conversion features from the host contract for convertible instruments. Either a modified retrospective method of transition or a fully retrospective method of transition is permissible for the adoption of this standard. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. The Company adopted ASU 2020-06 on July 1, 2022, with no material effect on the Company’ s current financial position, results of operations or financial statement disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Issued and Not Effective</span> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective date. Unless otherwise discussed, management believes that the impact of recently issued standards did not or will not have a material impact on the Company’s consolidated financial statements upon adoption.</span></p> <p id="xdx_85E_zC7pWqHOelZb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--UseOfEstimates_zlREYWvsDhz1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zaqo5ASZFNv2">Use of Estimates</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the deferred income tax asset valuations, convertible debt valuations, and share-based compensation. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between estimates and the actual results, future results of operations will be affected.</span></p> <p id="xdx_854_zieHcxzICXv8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"> </p> <p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_zvLLowsLfXg5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86A_zXozC3aTlA6h">Basic and Diluted Earnings per Share</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic net loss per share is computed by dividing net loss by the weighted average number of the Company’s common shares, no par value (“Common Shares”) outstanding during the period. Diluted net loss per share is computed by dividing the net loss by the weighted-average number of Common Share equivalents outstanding for the period determined using the treasury stock method or the if-converted method, as applicable. For purposes of this calculation, options to purchase Common Shares (“Options”) and warrants to purchase Common Shares (“Warrants”) are considered to be Common Share equivalents and are only included in the calculation of diluted net loss per share when their effect is dilutive. The following shares underlying Options, Warrants, and outstanding convertible debt were antidilutive due to a net loss in the periods presented and, therefore, were excluded from the dilutive securities computation for the three- and six-month periods ended December 31, 2022 and 2021, as indicated below.</span></p> <p id="xdx_89B_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_zvLfZM1C7HTj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zdcTZy18jhs2" style="display: none; visibility: hidden">Schedule of excluded from the dilutive securities</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td> </td> <td colspan="6" style="text-align: center">For the three and six months ended December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Excluded potentially dilutive securities <sup id="xdx_F60_zlhgDNkA7r95">(1)</sup>:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 74%">Options</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20220701__20221231_fKDEp_zZuGdeRZT0Zj" style="width: 10%; text-align: right" title="Options">9,960,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20210701__20211231_fKDEp_zDi7CYKUF6kl" style="width: 10%; text-align: right">18,315,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20220701__20221231_fKDEp_z4TEo7SS0jo" style="text-align: right" title="Warrants">18,016,253</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20210701__20211231_fKDEp_zBuBcX72LoX2" style="text-align: right">13,470,118</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Convertible debt</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20220701__20221231_fKDEp_zRukupS3qJde" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt">816,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20210701__20211231_fKDEp_zsHjkYUlCK84" style="border-bottom: Black 1pt solid; text-align: right">7,804,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Total potential dilutive securities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 2pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_uShares_c20220701__20221231_fKDEp_zXCXebrpKQk1" style="border-bottom: Black 2pt solid; text-align: right" title="Total potential dilutive securities">28,792,253</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 2pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_uShares_c20210701__20211231_fKDEp_zJLeb4HSMnC5" style="border-bottom: Black 2pt solid; text-align: right">39,589,118</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<i id="xdx_F04_zXPM56sqdZj5">1</i>)</span></td><td style="text-align: justify"><span id="xdx_F1C_zmXUUJM5eZx6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as of the period end. Such amounts have <i>not</i> been adjusted for the treasury stock method or weighted average outstanding calculations as required if the securities were dilutive.</span></td> </tr></table> <p id="xdx_8A8_zo5ayLDRcP1f" style="margin-top: 0; margin-bottom: 0"> </p> <p id="xdx_850_zLRsTDnKn4x2" style="margin-top: 0; margin-bottom: 0"> </p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_zlREYWvsDhz1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zaqo5ASZFNv2">Use of Estimates</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the deferred income tax asset valuations, convertible debt valuations, and share-based compensation. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between estimates and the actual results, future results of operations will be affected.</span></p>
	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	9960000	shares
	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	18315000	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	18016253	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	13470118	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	816000	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	7804000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	28792253	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	39589118	shares
CY2021Q4	us-gaap	Interest Expense InterestExpense	1022000	usd
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3992000	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-3992000	usd
CY2021Q4	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-14000	usd
CY2021Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4006000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	13263000	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-3992000	usd
CY2021Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-14000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	14296000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-164000	usd
	us-gaap	Interest Expense InterestExpense	1627000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6080000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6080000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	110000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5970000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6080000	usd
	us-gaap	Accretion Expense AccretionExpense	1524000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	739000	usd
	niobf	Foreign Currency Transaction Gain Loss Before Tax1 ForeignCurrencyTransactionGainLossBeforeTax1	-225000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	13213000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6080000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	110000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	14296000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6080000	usd
CY2022Q4	niobf	Working Capital WorkingCapital	6552000	usd
CY2022Q4	niobf	Cash And Cash Equivalents At Carrying Value1 CashAndCashEquivalentsAtCarryingValue1	424000	usd
	us-gaap	Deferred Policy Acquisition Costs Text Block1 DeferredPolicyAcquisitionCostsTextBlock1	<p id="xdx_805_eus-gaap--DeferredPolicyAcquisitionCostsTextBlock1_z1w0Ahspjvp6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_821_z9aUDCnklBs3">DEFERRED TRANSACTION COSTS</span></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has deferred third-party costs, including legal fees, other professional and consulting fees, and due diligence fees, incurred in connection with the proposed transaction discussed in Note 14. These costs are deferred until closing, at which time a portion of the directly attributable costs will be recorded against convertible debt to be entered into in connection with the proposed transaction, with the remainder treated as a reduction to the value of Common Shares issued.</span></p>
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	3431000	usd
CY2022Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	115000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	654000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	200000	usd
CY2022Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	102000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	48000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	48000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	4520000	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	817000	usd
	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	515000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14464000	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2605819	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1898181	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9960000	shares
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	9960000	shares
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	9960000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2022Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	18516253	shares
	niobf	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	-500000	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	18016253	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	18016253	shares
CY2022Q4	us-gaap	Exploration Expense ExplorationExpense	1317000	usd
CY2021Q4	us-gaap	Exploration Expense ExplorationExpense	491000	usd
	us-gaap	Exploration Expense ExplorationExpense	2605000	usd
	us-gaap	Exploration Expense ExplorationExpense	1112000	usd
CY2022Q4	niobf	Fixed Rent Expense FixedRentExpense	23000	usd
CY2021Q4	niobf	Fixed Rent Expense FixedRentExpense	23000	usd
	niobf	Fixed Rent Expense FixedRentExpense	44000	usd
	niobf	Fixed Rent Expense FixedRentExpense	43000	usd
CY2022Q4	us-gaap	Variable Lease Cost VariableLeaseCost	3000	usd
CY2021Q4	us-gaap	Variable Lease Cost VariableLeaseCost	2000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	6000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	5000	usd
CY2022Q4	us-gaap	Short Term Lease Cost ShortTermLeaseCost	3000	usd
CY2021Q4	us-gaap	Short Term Lease Cost ShortTermLeaseCost	2000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	5000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	9000	usd
CY2022Q4	us-gaap	Sublease Income SubleaseIncome	12000	usd
CY2021Q4	us-gaap	Sublease Income SubleaseIncome	10000	usd
	us-gaap	Sublease Income SubleaseIncome	18000	usd
	us-gaap	Sublease Income SubleaseIncome	15000	usd
CY2022Q4	us-gaap	Lease Cost LeaseCost	17000	usd
CY2021Q4	us-gaap	Lease Cost LeaseCost	17000	usd
	us-gaap	Lease Cost LeaseCost	37000	usd
	us-gaap	Lease Cost LeaseCost	42000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	70000	usd
CY2022Q4	niobf	Less Amount Of Payments Representing Interest LessAmountOfPaymentsRepresentingInterest	4000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	66000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	424000	usd
CY2022Q4	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	9000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	433000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	5280000	usd
CY2022Q2	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	10000	usd
CY2022Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	5290000	usd
CY2022Q4	us-gaap	Cash Cash	15000000.0	usd
CY2022Q3	us-gaap	Investment Company Expense Ratio Voluntary Fee Waiver InvestmentCompanyExpenseRatioVoluntaryFeeWaiver	0.15	pure
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	5000000.0	usd
CY2022Q4	us-gaap	Regulatory Liabilities RegulatoryLiabilities	200000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001539497-23-000271-index-headers.html	Edgar Link	pending
0001539497-23-000271-index.html	Edgar Link	pending
0001539497-23-000271.txt	Edgar Link	pending
0001539497-23-000271-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
n2574_x85-10q.htm	Edgar Link	pending
n2574_x85-img001.jpg	Edgar Link	pending
niobf-20221231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
niobf-20221231_cal.xml	Edgar Link	unprocessable
niobf-20221231_def.xml	Edgar Link	unprocessable
niobf-20221231_lab.xml	Edgar Link	unprocessable
niobf-20221231_pre.xml	Edgar Link	unprocessable
n2574_x85-10q_htm.xml	Edgar Link	completed
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NB
NIOCORP DEVELOPMENTS LTD Stock $nb

2023 Q1 Form 10-Q Financial Statement

#000153949723000271 Filed on February 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NB NIOCORP DEVELOPMENTS LTD Stock $nb

2023 Q1 Form 10-Q Financial Statement

#000153949723000271 Filed on February 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NB
NIOCORP DEVELOPMENTS LTD Stock $nb